A boost for NervGen’s spinal cord injury trials
Following the success of its phase I clinical trial, NervGen will initiate a phase Ib/IIa trial as early as Q3 this year to demonstrate...
Defence Therapeutics completes AccuTOXTM preclinical efficacy studies
Defence Therapeutics has successfully completed all essential preclinical efficacy studies for the company’s AccuTOXTM programme.
AccuTOXTM is one of Defence’s most advanced research and development...
Pioneering approaches to gynaecological cancer diagnostics
Lorna Rothery spoke to Marina Rigau, CEO and Co-Founder of EIT Health-supported start-up MiMARK, about the challenges associated with the diagnosis of gynaecological conditions.
By...
How to tackle social care recruitment challenges
Laura Wolstenholme, Head of Workforce at Persona Care and Support, outlines the importance of training opportunities within the social care sector.
Recruitment and retention challenges...
Emergency care at crisis point
Long-established issues in the health system are being reflected in emergency care, bold actions are needed to address this.
Making rare disease medicines less rare: The EU must take this opportunity to effect...
Revision of the OMP Regulation holds opportunities for improving the lives of those living with a rare disease.
A call to action: Addressing inequalities between European healthcare systems
We must rethink the structure of healthcare systems and workforce strategies across the EU and address geographic disparities of healthcare professionals.
Defence Therapeutics granted US patent for vaccine enhancer technology
Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
European Patients’ Rights Day and ATMPs: Combining sustainability, innovation and respect for patients’ rights
Mariano Votta and Bianca Ferraiolo from the Cittadinanzattiva-Active Citizenship Network discuss this year’s European Patients’ Rights Day which focuses on Advanced Therapy Medicinal Products...
The ultimate guide to gut microbiota and the human microbiome
Our complete guide to gut microbiota and the human microbiome details essential information to help optimise your gut health.
Gut microbiota and the human microbiome...
How the potential of biosimilar medications can be unlocked
Health Europa details everything you need to know about biosimilar medications, their benefits, safety, success stories, and how biosimilars can revolutionise healthcare.
The potential of...
Striving for more in cancer care and prevention
Despite vast improvements in cancer care, challenges remain in driving forward cancer prevention strategies.
Defence Therapeutics’ mRNA cancer vaccine testing begins
Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started.
The performance of Defence’s AccumTM mRNA cancer...
The rising demand for regenerative therapies and personalised medicine
Health Europa brings you the ultimate guide to regenerative therapies and personalised medicine, and highlights their ability to bring about more effective treatment methods for...
Defence Therapeutics successfully develops ACCUMTM -mRNA cancer vaccine
Canadian biopharmaceutical pioneer Defence Therapeutics has revealed it has successfully conjugated mRNA molecules to AccumTM – a significant breakthrough that looks to enhance the...
Respiratory viruses and infection control
Lorna Rothery spoke to Dr Albert Osterhaus, expert virologist and Chairman of the European Scientific Working group on Influenza and other Respiratory Viruses about...
Dealing with health anxiety during a healthcare crisis
Anxiety UK, a leading charity, spoke with Monet Bailey at Health Europa about health anxiety, how to deal with symptoms and policy measures to...
Biopharmaceuticals – the complete guide to the future of medicine
Health Europa provides a comprehensive analysis of biopharmaceuticals to evaluate their significant potential to treat a range of diseases and their cost and value...
Curbing appetites for ultra-processed foods
Ultra-processed foods have been linked to a range of health implications, but the level of consumption remains high. We spoke to researchers at Imperial...
Regularly eating nuts and seeds can reduce the risk of heart disease
Frequently eating nuts and seeds can reduce the risk of heart disease and stroke, according to a new study from the University of Oslo.
Diets...